Total Funding
83
46
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24415
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
David Siewers: Interim CFOPast Role: Selecta Biosciences, Vice President Finance- Philip Ma: Chief Executive Officer, President & Founder
About the Company
PrognomiQ is a technology company that focuses on transforming early disease detection and treatment through multi-omics data. The company generates extensive proteomic, genomic, and metabolomic data to provide insights into complex diseases, aiming to improve patient outcomes. PrognomiQ's innovative approach facilitates the development of
advanced test products that enhance the understanding and management of health conditions.
